Bayer Foundation Women Entrepreneurs Award: 2026 Cycle Archive and Next Application Phase

Bayer Foundation Women Entrepreneurs Award: 2026 Cycle Archive and Next Application Phase

The Bayer Foundation Women Entrepreneurs Award 2026 application cycle is closed, and its 15 awardees have been selected and announced. Applications ran from 2 March through 13 April 2026; the official award site gives the closing time as 23:59 CEST on 13 April. Bayer Foundation says the next application phase will start in November/December 2026. That is month-level timing, not an open application window: exact dates and the next call’s rules are not yet published. This page preserves the completed 2026 cycle as a historical reference; it is not an application form.

The official Bayer Foundation programme page describes the award as annual and says the next application phase will start in November/December 2026. It does not give exact opening or closing days or publish the next call’s rules. The award site has announced the 15 winners selected from 1,172 applicants and retains the 2026 programme information, including a community priority list for news of the next cohort. Until a new call is published, treat the amount, eligibility, and application process below as facts about the closed 2026 round only. Recheck the Bayer Foundation programme page, the official 2026 winners announcement, and the official award site for the next call.

Verified status at a glance

The archived deadline in the front matter is the genuine closing date for the completed cycle. It is not a suggested date for a future applicant. Bayer Foundation’s winners announcement confirms that selection is complete: 15 women entrepreneurs were chosen from 1,172 applications, with five awardees from each of the three programme regions. historicalReference = true tells the site and reader that this is a finished round while preserving useful programme information.

What the 2026 award offered

The central award was €25,000 in non-dilutive funding. The official programme site says the money could be used flexibly to support business growth, expand reach, and invest in the next stage of the venture. It also says that the programme did not provide additional direct investment beyond the cash prize. The purpose of the accelerator was to improve investor readiness and create investor-facing opportunities through learning sessions, pitches, and ecosystem connections.

The award was also a six-month accelerator. Support was tailored to each venture rather than presented as a single generic class. Selected awardees completed an onboarding interview and baseline survey, were matched with a business advisor for regular one-to-one sessions, and joined group sessions with experts and peers at least once a month. The official site gave an expected commitment of at least four hours per month.

The group curriculum covered business and growth planning, financial planning and fundamentals, funding pathways and alternative financing, pitching, storytelling, and communications. That combination matters for an impact venture: a strong social purpose does not by itself explain the revenue model, operating costs, demand, or route to scale. The programme was designed to help founders make those points clear to investors and other partners.

The 2026 award also included visibility support, participation in a Bayer Foundation women-led alumni community, and access to the Impact Hub Network. The sponsored in-person programme experience was scheduled in Amsterdam from 26–30 October 2026 for Awardee Days and the Award Ceremony. The official FAQ says the sponsored trip included international travel, travel insurance, accommodation, visa expenses, event participation including catering, and a daily allowance of €35 per day; additional personal expenses remained the awardee’s responsibility.

Who qualified for the 2026 cycle

The official criteria were specific about stage, leadership, geography, sector, traction, and legal form. An applicant needed to be a woman founder, co-founder, or senior leader with decision-making power in an operating venture beyond the idea stage. The venture needed to address health and/or food security challenges and deliver measurable impact for low- and middle-income communities in Asia, Latin America, Africa and/or the Middle East.

The programme was not limited to companies that had already reached profitability. The official site accepted ventures with annual revenue up to USD 1,000,000 and also described eligibility for pre-break-even businesses that could show strong evidence of growing revenue and demand. It listed start-up stage ventures with a working model and early traction, growth-stage ventures building repeatable operations and demand, and scaling-stage ventures expanding into new markets or substantially increasing reach. Idea-stage concepts were not eligible.

The accepted organisational forms were equally important. A social enterprise meant a for-profit venture with a social or environmental mission. Hybrid models combining a non-profit and a for-profit entity could apply. A non-profit could apply only if it had a clear pathway and intent to launch or convert to a for-profit entity within 12–24 months and met the other requirements. The organisation had to be incorporated on or before 1 January 2025. Registered charities and sole traders were expressly excluded.

Focus areas

The official award site divided the brief into health and food security.

Health examples included cardiovascular health, including climate-related risks such as heat stress and stroke care; women’s health across the life cycle; oncology, especially cancers affecting women; healthcare payment and insurance models; and tools that support community health workers or digital health infrastructure in underserved areas.

Food security examples included reducing food waste across production, storage, distribution, retail, and consumption; reducing malnutrition through better diets and micronutrient access; fair markets and pricing; increasing smallholder farmer productivity, resilience, and income; and water justice and sanitation. A strong application needed to explain the concrete problem, the customer or user, the operating model, and how impact was measured. Merely attaching a broad social label to a product would not satisfy the published focus.

How the 2026 application process worked

The official programme timeline described the 2026 application period as 2 March–13 April. Applicants submitted information about their venture, impact, and growth ambitions through the Impact Hub application route. The application phase is closed now, and the archived application route should not be treated as open for a later cycle until the organisers publish the next call.

The selection process had a clear second stage. The official FAQ says applications were reviewed by Bayer Foundation, Impact Hub, and external experts. The top 30 finalists were invited to pitch online to a jury. From those finalists, 15 awardees were selected for the six-month programme, with five selected per region. The final jury included representatives from Bayer Foundation, the Impact Hub Network, and partner ecosystem organisations.

For a future intake, an applicant should be ready to explain five things in plain terms:

1. The operating venture. State what is already working, who uses or buys it, where it operates, and what evidence shows that the model is beyond an idea.
2. The measurable problem. Connect the product or service to a health or food security outcome for low- and middle-income communities. Use a small number of defined metrics rather than broad claims.
3. The growth case. Explain current traction, revenue or demand evidence, the next bottleneck, and why this programme fits the venture’s stage.
4. The legal and leadership facts. Confirm the woman founder, co-founder, or senior leader’s decision-making role, the organisation type, and the incorporation date.
5. The use of support. Show how business advising, financial work, impact measurement, communications, and the non-dilutive cash would support a specific next stage.

The official page reviewed does not publish a universal attachment checklist. Applicants should therefore follow the fields and instructions in the live application form when the next intake opens rather than assuming that a later portal will ask for the same files. Keeping a current venture summary, revenue and demand evidence, impact measurements, legal-status details, team information, and a concise growth plan ready will make that later submission easier without turning those preparations into invented mandatory documents.

What to do before the next application phase

November/December 2026 is the only timing currently stated for the next application phase by the official Bayer Foundation source. The Foundation has not given an exact opening day or closing deadline, nor published whether that call will change the prize, eligible regions, sector language, incorporation cutoff, revenue guidance, finalist process, or travel and time-commitment requirements. The next application period is not yet open in the verified material for this update. Join the official priority list or revisit the programme pages, then read the new call before preparing a submission against the earlier rules.

The 2026 archive remains useful because it records the programme’s previous structure and the kind of evidence organisers requested: an operating impact business, measurable outcomes, a credible path to growth, and a leader with authority to execute. It should not be used to claim that applications are open, that €25,000 is guaranteed for a future cohort, or that the 2026 deadline has been extended.

Frequently asked questions

Can I still apply for the 2026 award?

No. The 2026 application window ran from 2 March through 13 April 2026, closing at 23:59 CEST on 13 April. The official winners announcement confirms that 15 awardees have since been selected.

When is the next round?

The Bayer Foundation’s current women entrepreneurs page says the next application phase will start in November/December 2026. It does not give an exact opening or closing day or publish updated eligibility rules, so this page cannot provide them.

Is the €25,000 a loan or an equity investment?

The 2026 award was described as €25,000 in non-dilutive cash support. The official FAQ says the programme did not provide additional direct investment beyond that cash prize.

Could an idea-stage founder apply?

No for the 2026 criteria. The venture had to be operating beyond the idea stage, with a working model and traction or strong evidence of growing revenue and demand.

Could a non-profit apply?

Yes, but only with a clear pathway and intent to launch or convert to a for-profit entity within 12–24 months. Registered charities and sole traders were not eligible under the published 2026 rules.

What should a future applicant verify first?

Start with the new official call. Confirm that the application window is open, then read the updated eligibility and form instructions rather than copying the archived 2026 rules. The official contact listed for programme questions is [email protected].

The verified record is specific to a completed year: the 2026 round closed on 13 April, and Bayer Foundation and Impact Hub announced 15 winners from 1,172 applicants. Each winner receives €25,000 and six months of support. Bayer Foundation says the next application phase starts in November/December 2026, but has not published exact dates or new-cycle rules yet.